Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abionic SA

www.abionic.com

Latest From Abionic SA

OUS Approvals Analysis: Medtronic, Abbott, Abionic Lead 2017 Upswing

The 20 non-US medical device approvals in January, including eight in in vitro diagnostics, four in orthopedics, and three in cardiovascular devices. Big medtech players Medtronic and Abbott, accompanied by much smaller Swiss IVD firm Abionic, led the charge and bagged more OUS approvals than most.

Approvals Research & Development

Abionic's New POC Sepsis Test On Rapid Move To Market

Swiss start-up Abionic has CE marked rapid tests for sepsis and iron deficiency, designed to run on its diagnostics platform abioSCOPE. The new sepsis test is based on a new biomarker PSP which has shown to be superior to current tests in detecting this life threatening condition early.

In Vitro Diagnostics Approvals

Emergings In Brief, May 2012

Brief profiles of these recently formed companies: Abionic, Alcresta, Avenir Medical and Milo Biotechnology.

Medical Device BioPharmaceutical

Out Of The Blocks, May 2012

Brief profiles of these recently formed companies: Abionic, Alcresta, Avenir Medical, Avion Pharmaceuticals, Ground Fluor Pharmaceuticals and Milo Biotechnology.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Abionic SA
  • Senior Management
  • Nicolas Durand, PhD, CEO
  • Contact Info
  • Abionic SA
    Phone: 79 753 57 66
    c/o EPFL - STI - LOB - BM4247
    Station 17
    Lausanne, 1015
    Switzerland
UsernamePublicRestriction

Register